US 8043622
Method of treating inflammatory lung disease with suppressors of CpG oligonucleotides
granted A61PA61P11/00A61P11/08
Quick answer
US patent 8043622 (Method of treating inflammatory lung disease with suppressors of CpG oligonucleotides) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61P, A61P11/00, A61P11/08, A61P11/10, A61P29/00